These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21219589)

  • 21. Prevalence of aspirin resistance in stroke patients in Phramongkutklao Hospital.
    Nidhinandana S; Changchit S
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S51-4. PubMed ID: 21280515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].
    Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H
    Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of aspirin response by Multiplate whole blood aggregometry and light transmission aggregometry.
    Pedersen SB; Grove EL; Nielsen HL; Mortensen J; Kristensen SD; Hvas AM
    Platelets; 2009 Sep; 20(6):415-20. PubMed ID: 19658002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 25. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
    Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
    Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of obesity on platelet reactivity and response to low-dose aspirin.
    Bordeaux BC; Qayyum R; Yanek LR; Vaidya D; Becker LC; Faraday N; Becker DM
    Prev Cardiol; 2010; 13(2):56-62. PubMed ID: 20377806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing aspirin responsiveness using the Verify Now Aspirin assay.
    Fontana P; Reber G; de Moerloose P
    Thromb Res; 2008; 121(4):581-2. PubMed ID: 17559908
    [No Abstract]   [Full Text] [Related]  

  • 29. Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance.
    Stef G; Csiszar A; Lerea K; Ungvari Z; Veress G
    J Cardiovasc Pharmacol; 2006 Aug; 48(2):1-5. PubMed ID: 16954814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
    Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis?
    von Lewinski F; Riggert J; Paulus W
    J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.
    Bach J; Kammerer I; Isgro F; Haubelt H; Vogt A; Saggau W; Hellstern P
    Platelets; 2009 May; 20(3):150-7. PubMed ID: 19437331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment.
    Sibbing D; Braun S; Jawansky S; Vogt W; Mehilli J; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2008 Jan; 99(1):121-6. PubMed ID: 18217143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for aspirin resistance in stable coronary artery patients by three different tests.
    Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I
    Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
    Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
    Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers.
    Siller-Matula JM; Gouya G; Wolzt M; Jilma B
    Thromb Haemost; 2009 Aug; 102(2):397-403. PubMed ID: 19652892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors responsible for "aspirin resistance" - can we identify them?
    Postuła M; Tarchalska-Kryńska B; Filipiak KJ; Kosior D; Serafin A; Huczek Z; Opolski G
    Kardiol Pol; 2010 Apr; 68(4):403-11; discussion 412-3. PubMed ID: 20425699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical aggregometry and aspirin resistance.
    Feher G; Pusch G; Szapary L
    Acta Neurol Scand; 2009 Feb; 119(2):139; author reply 140. PubMed ID: 18647274
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
    J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.